Tales Henrique Andrade da Mota, Ana Flávia Reis Guimarães, Amandda Évelin Silva de Carvalho, Felipe Saldanha-de Araujo, Giselle Pinto de Faria Lopes, Fábio Pittella-Silva, Doralina do Amaral Rabello, Diêgo Madureira de Oliveira
BACKGROUND: The inhibition of the enzyme telomerase (TERT) has been widely investigated as a new pharmacological approach for cancer treatment, but its real potential and the biochemical consequences are not totally understood. OBJECTIVE: Here, we investigated the effects of the telomerase inhibitor MST-312 on a human glioma cell line after both short- and long-term (290 days) treatments. METHODS: Effects on cell growth, viability, cell cycle, morphology, cell death and genes expression were assessed...
2021: Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine